128 related articles for article (PubMed ID: 25617485)
1. HSD17B1 expression enhances estrogen signaling stimulated by the low active estrone, evidenced by an estrogen responsive element-driven reporter gene in vivo.
Järvensivu P; Saloniemi-Heinonen T; Awosanya M; Koskimies P; Saarinen N; Poutanen M
Chem Biol Interact; 2015 Jun; 234():126-34. PubMed ID: 25617485
[TBL] [Abstract][Full Text] [Related]
2. Human hydroxysteroid (17-beta) dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenografts.
Husen B; Huhtinen K; Saloniemi T; Messinger J; Thole HH; Poutanen M
Endocrinology; 2006 Nov; 147(11):5333-9. PubMed ID: 16916945
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Human Estrogen Biosynthetic Enzyme Hydroxysteroid (17beta) Dehydrogenase Type 1 Induces Adenomyosis-like Phenotype in Transgenic Mice.
Heinosalo T; Rytkönen KT; Saarinen N; Järvensivu P; Damdimopoulou P; Strauss L; Orasniemi S; Horshauge P; Gabriel M; Koskimies P; Ohlsson C; Kronqvist P; Poutanen M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563206
[TBL] [Abstract][Full Text] [Related]
4. Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice.
Saloniemi T; Järvensivu P; Koskimies P; Jokela H; Lamminen T; Ghaem-Maghami S; Dina R; Damdimopoulou P; Mäkelä S; Perheentupa A; Kujari H; Brosens J; Poutanen M
Am J Pathol; 2010 Mar; 176(3):1443-51. PubMed ID: 20093485
[TBL] [Abstract][Full Text] [Related]
5. HSD17B1 expression induces inflammation-aided rupture of mammary gland myoepithelium.
Järvensivu P; Heinosalo T; Hakkarainen J; Kronqvist P; Saarinen N; Poutanen M
Endocr Relat Cancer; 2018 Apr; 25(4):393-406. PubMed ID: 29371331
[TBL] [Abstract][Full Text] [Related]
6. Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.
Konings GF; Cornel KM; Xanthoulea S; Delvoux B; Skowron MA; Kooreman L; Koskimies P; Krakstad C; Salvesen HB; van Kuijk K; Schrooders YJ; Vooijs M; Groot AJ; Bongers MY; Kruitwagen RF; ; Romano A
J Pathol; 2018 Feb; 244(2):203-214. PubMed ID: 29144553
[TBL] [Abstract][Full Text] [Related]
7. In vivo mouse model for analysis of hydroxysteroid (17beta) dehydrogenase 1 inhibitors.
Lamminen T; Saloniemi T; Huhtinen K; Koskimies P; Messinger J; Husen B; Thole H; Poutanen M
Mol Cell Endocrinol; 2009 Mar; 301(1-2):158-62. PubMed ID: 19026716
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.
Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
Lung Cancer; 2015 Feb; 87(2):107-16. PubMed ID: 25564397
[TBL] [Abstract][Full Text] [Related]
9. Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer.
Gunnarsson C; Jerevall PL; Hammar K; Olsson B; Nordenskjöld B; Jansson A; Stål O
Breast Cancer Res Treat; 2008 Mar; 108(1):35-41. PubMed ID: 17457667
[TBL] [Abstract][Full Text] [Related]
10. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
11. Increased 17ß-hydroxysteroid dehydrogenase type 1 levels in primary cervical cancer.
Tomaszewska A; Roszak A; Pawlik P; Sajdak S; Jagodziński PP
Biomed Pharmacother; 2015 May; 72():179-83. PubMed ID: 26054693
[TBL] [Abstract][Full Text] [Related]
12. Expression of 17β-hydroxysteroid dehydrogenase type 1 in gastric cancer.
Frycz BA; Murawa D; Wysocki-Borejsza M; Marciniak R; Murawa P; Drews M; Jagodziński PP
Biomed Pharmacother; 2013 Sep; 67(7):651-7. PubMed ID: 23916544
[TBL] [Abstract][Full Text] [Related]
13. Sex steroid-dependent and -independent action of hydroxysteroid (17beta) Dehydrogenase 2: evidence from transgenic female mice.
Shen Z; Saloniemi T; Rönnblad A; Järvensivu P; Pakarinen P; Poutanen M
Endocrinology; 2009 Nov; 150(11):4941-9. PubMed ID: 19797119
[TBL] [Abstract][Full Text] [Related]
14. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
Hevir-Kene N; Rižner TL
Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
[TBL] [Abstract][Full Text] [Related]
15. A new nonestrogenic steroidal inhibitor of 17β-hydroxysteroid dehydrogenase type I blocks the estrogen-dependent breast cancer tumor growth induced by estrone.
Ayan D; Maltais R; Roy J; Poirier D
Mol Cancer Ther; 2012 Oct; 11(10):2096-104. PubMed ID: 22914440
[TBL] [Abstract][Full Text] [Related]
16. Activation of androgens by hydroxysteroid (17beta) dehydrogenase 1 in vivo as a cause of prenatal masculinization and ovarian benign serous cystadenomas.
Saloniemi T; Lamminen T; Huhtinen K; Welsh M; Saunders P; Kujari H; Poutanen M
Mol Endocrinol; 2007 Nov; 21(11):2627-36. PubMed ID: 17666583
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-related receptor γ regulates expression of 17β-hydroxysteroid dehydrogenase type 1 in fetal growth restriction.
Zhu H; Huang L; He Z; Zou Z; Luo Y
Placenta; 2018 Jul; 67():38-44. PubMed ID: 29941172
[TBL] [Abstract][Full Text] [Related]
18. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of inhibitors for 17beta-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme.
Husen B; Huhtinen K; Poutanen M; Kangas L; Messinger J; Thole H
Mol Cell Endocrinol; 2006 Mar; 248(1-2):109-13. PubMed ID: 16406284
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of 17β-hydroxysteroid dehydrogenase impairs human endometrial cancer growth in an orthotopic xenograft mouse model.
Xanthoulea S; Konings GFJ; Saarinen N; Delvoux B; Kooreman LFS; Koskimies P; Häkkinen MR; Auriola S; D'Avanzo E; Walid Y; Verhaegen F; Lieuwes NG; Caiment F; Kruitwagen R; ; Romano A
Cancer Lett; 2021 Jun; 508():18-29. PubMed ID: 33762202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
